Jane Jackman

Dr. Jane Jackman

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2012 in WIREs RNA
Verified
Journal Article
Closed access
PDF file
JJJane Jackman
Jane Jackman
JAJuan Alfonzo
Juan Alfonzo

1 February 1999 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
TOTeru Ogura
Teru Ogura
KIKoichi Inoue
Koichi Inoue
TTTakashi Tatsuta
Takashi Tatsuta
TSToshinobu Suzaki
Toshinobu Suzaki
KKKiyonobu Karata
Kiyonobu Karata
HMHiroshi Matsuzawa
Hiroshi Matsuzawa

1 May 2003 in RNA
Verified
Journal Article
Open access
PDF file
JJJane Jackman
Jane Jackman
RMRebecca K. Montange
Rebecca K. Montange
HMHarmit S. Malik
Harmit S. Malik
EPEric M. Phizicky
Eric M. Phizicky
Methylation of tRNA at the N-1 position of guanosine to form m1G occurs widely in nature. It occurs at position 37 in tRNAs from all three kingdoms, and the methyltransferase that catalyzes this reaction is known from previous work of others to be critically important for cell growth in Escherichia coli and the yeast Saccharomyces cerevisiae. m1G is also widely found at position 9 in eukaryotic tRNAs, but the corresponding methyltransferase was unknown. We have used a biochemical genomics approach with a collection of purified yeast GST-ORF fusion proteins to show that m1G9 formation of yeast tRNAGly is associated with ORF YOL093w, named TRM10. Extracts lacking Trm10p have undetectable levels of m1G9 methyltransferase activity but retain normal m1G37 methyltransferase activity. Yeast Trm10p purified from E. coli quantitatively modifies the G9 position of tRNAGly in an S-adenosylmethionine-dependent fashion. Trm10p is responsible in vivo for most if not all m1G9 modification of tRNAs, based on two results: tRNAGly purified from a trm10-Δ/trm10-Δ strain is lacking detectable m1G; and a primer extension block occurring at m1G9 is removed in trm10-Δ/trm10-Δ-derived tRNAs for all 9 m1G9-containing species that were testable by this method. There is no obvious growth defect of trm10-Δ/trm10-Δ strains. Trm10p bears no detectable resemblance to the yeast m1G37 methyltransferase, Trm5p, or its orthologs. Trm10p homologs are found widely in eukaryotes and many archaea, with multiple homologs in several metazoans, including at least three in humans.

1 April 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JJJane Jackman
Jane Jackman
CFCarol A. Fierke
Carol A. Fierke
LTL. Nathan Tumey
L. Nathan Tumey
MPMichael Pirrung
Michael Pirrung
TUTaketo Uchiyama
Taketo Uchiyama
CRChristian R. H. Raetz
Christian R. H. Raetz
UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) catalyzes the second step in the biosynthesis of lipid A, a unique amphiphilic molecule found in the outer membranes of virtually all Gram-negative bacteria. Since lipid A biosynthesis is required for bacterial growth, inhibitors of LpxC have potential utility as antibiotics. The enzymes of lipid A biosynthesis, including LpxC, are encoded by single copy genes in all sequenced Gram-negative genomes. We have now cloned, overexpressed, and purified LpxC from the hyperthermophile Aquifex aeolicus. This heat-stable LpxC variant (the most divergent of all known LpxCs) displays 32% identity and 51% similarity over 277 amino acid residues out of the 305 inEscherichia coli LpxC. Although A. aeolicusLpxC deacetylates the substrate UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine at a rate comparable with E. coli LpxC, a phenyloxazoline-based hydroxamate that inhibits E. coliLpxC with K i of ∼50 nm (Onishi, H. R., Pelak, B. A., Gerckens, L. S., Silver, L. L., Kahan, F. M., Chen, M. H., Patchett, A. A., Galloway, S. M., Hyland, S. A., Anderson, M. S., and Raetz, C. R. H. (1996) Science 274, 980–982) does not inhibit A. aeolicus LpxC. To determine whether or not broad-spectrum deacetylase inhibitors can be found, we have designed a new class of hydroxamate-containing inhibitors of LpxC, starting with the structure of the physiological substrate. Several of these compounds inhibit both E. coli and A. aeolicus LpxC at similar concentrations. We have also identified a phosphinate-containing substrate analog that inhibits both E. coli and A. aeolicus LpxC, suggesting that the LpxC reaction proceeds by a mechanism similar to that described for other zinc metalloamidases, like carboxypeptidase A and thermolysin. The differences between the phenyloxazoline and the substrate-based LpxC inhibitors might be exploited for developing novel antibiotics targeted either against some or all Gram-negative strains. We suggest that LpxC inhibitors with antibacterial activity be termed “deacetylins.”

22 January 1999 in Biochemistry
Verified
Journal Article
Closed access
JJJane Jackman
Jane Jackman
CRChristian R. H. Raetz
Christian R. H. Raetz
CFCarol A. Fierke
Carol A. Fierke

1 January 2003 in Genes & Development
Verified
Journal Article
Open access
PDF file
WGWeifeng Gu
Weifeng Gu
JJJane Jackman
Jane Jackman
ALAmanda J. Lohan
Amanda J. Lohan
MGMichael W. Gray
Michael W. Gray
EPEric M. Phizicky
Eric M. Phizicky
All tRNAHis molecules are unusual in having an extra 5′ GMP residue (G-1) that, in eukaryotes, is added after transcription and RNase P cleavage. Incorporation of this G-1 residue is a rare example of nucleotide addition occurring at an RNA 5′ end in a normal phosphodiester linkage. We show here that the essential Saccharomyces cerevisiae ORF YGR024c (THG1) is responsible for this guanylyltransferase reaction. Thg1p was identified by survey of a genomic collection of yeast GST-ORF fusion proteins for addition of [α-32P]GTP to tRNAHis. End analysis confirms the presence of G-1. Thg1p is required for tRNAHis guanylylation in vivo, because cells depleted of Thg1p lack G-1 in their tRNAHis.His6-Thg1p purified from Escherichia coli catalyzes the guanylyltransferase step of G-1 addition using a ppp-tRNAHis substrate, and appears to catalyze the activation step using p-tRNAHis and ATP. Thg1p is highly conserved in eukaryotes, where G-1 addition is necessary, and is not found in eubacteria, where G-1 is genome-encoded. Thus, Thg1p is the first member of a new family of enzymes that can catalyze phosphodiester bond formation at the 5′ end of RNAs, formally in a 3′-5′ direction. Surprisingly, despite its varied activities, Thg1p contains no recognizable catalytic or functional domains.